Dr. Natalie Stephens is the Scientific Director of Biofyl Scientific Research (BSR), a contract research organization providing scientific, analytical, and regulatory support to biotech clients.  She works closely with companies to ensure quality, compliance, and scientific rigor. Dr. Stephens is an accomplished researcher with extensive experience in medical device testing, clinical research, and scientific writing that supports regulatory submissions. As Scientific Director of BSR, she designs and oversees research studies and regulatory evidence generation for biosciences companies, with a focus on comparative and equivalence testing for autologous blood, bone marrow and lipoaspirate devices. Before joining BSR, Dr. Stephens completed her postdoctoral studies, working on clinical research programs at the Translational Research Institute for Metabolism and Diabetes, providing scientific input on study protocols, coordinating research projects, and publishing peer-reviewed work in human muscle metabolism and Type 2 Diabetes.  

Dr. Stephens earned her doctorate degree in biochemistry and molecular biology at the University of Georgia after originating multiple publications on protein trafficking and innate immunity. She earned her Bachelor’s Degree with honors in Biology at Williams College.